ABSTRACT

23
The enzyme glutamine synthetase serves key roles in central nitrogen metabolism, catalyzing the 24 biosynthesis of glutamine, as well as regulating ammonia assimilation and integrating metabolic 25 signals to balance nitrogen use. The budding yeast enzyme was recently found to form 26 intracellular bodies (GS bodies) composed of glutamine synthetase and Hsp90 chaperones 27 following various types of nutrient depletion or chemical stress. In order to better quantify and 28 characterize the in vivo formation of GS bodies, we developed an assay for their formation in 29 single yeast cells using imaging flow cytometry, which enables the quantitative measurement of 30 rates of GS body formation and their population penetrance. Either reduction of supplied 31 glucose, or addition of the competitive inhibitor of glycolysis, 2-deoxyglucose, markedly 32 enhanced the formation of GS bodies. The occurrence of GS bodies increased with increasing 33 cell size, a proxy for cell age, while treatment with rapamycin antagonized their formation.
34
Direct measurement of GS body formation as a function of replicative age showed that mother 35 cells exhibited a significantly higher incidence of GS bodies than daughter cells, and the 36 frequency of GS body formation increased with increasing replicative cell age. Thus, we find 37 that yeast glutamine synthetase bodies form in a manner strongly dependent on available glucose 38 and increase markedly with cell age. 
INTRODUCTION
45
Evidence is building that protein aggregation in vivo may be far more common than 46 expected, with widespread protein aggregation observed in fission yeast cells (Matsuyama et al. 47 In order to better understand the in vivo conditions that might drive a highly expressed, 90 soluble protein into compact, insoluble protein bodies, we developed a high-throughput single 91 cell assay for GS body formation based on imaging flow cytometry. Using this assay, we 92 quantified the formation of GS bodies in response to available glucose and cell age. In particular, 93
we hypothesized that depleting cellular energy levels would lead to less effective protein 94 homeostasis and a concomitant aggregation of Gln1p. Indeed, GS bodies have been previously 95 observed to form in stationary phase cells as well as in cells transferred into glucose dropout 96 medium (Narayanaswamy et al. 2009 )(e.g., as shown in Figure 1A ). We therefore quantified the 97 kinetic dependence of GS body formation on available glucose and in response to addition of an 98 inhibitor of hexokinase. We find that GS body formation is strongly dependent on glucose, as is 99 the number and size of bodies formed. Treatment with the compound rapamycin, which globally 100 reduces protein synthesis rates and increases levels of autophagy, strongly reduced the incidence 101 of GS bodies. Finally, the tendency to form GS bodies was strongly correlated with replicative lysing for mass spec analysis. All cultures were maintained shaking at 30°C.
119
For assays in the presence of 2-deoxy glucose, cells in late log phase, defined as an 120 optical density of 2/ml, were spun down, washed with SC-glucose, re-suspended in SC-glucose 121 with 2% 2-deoxyglucose (Sigma) for 2h shaking at 30C.
122
Cells were imaged on a Nikon E800 fluorescence microscope with Photometrix Coolsnap 123 CCD camera under oil immersion at 100x magnification. DIC images and fluorescent images in 124 the GFP channels were collected using standard filter sets. Cell lysate was imaged on a Nikon 125 TE2000-E with a Photometrics Cascade II camera at 60x magnification. Images were processed 126 using Nikon Elements AR. In order to determine the effects of increasing cell age on the formation of GS bodies, we 156 grew cultures of Gln1-GFP yeast to stationary phase in YPD (5 days) and fixed cells as described 157 above. Bud scars on cells were fluorescently marked by incubation for 20 minutes with 158 calcofluor-white (100 µl/ml PBS cell suspension). The brightest 1% of calcofluor-white 159 fluorescent cells were isolated using FACS, resulting in a population enriched for older mother 160 yeast cells. Cells were imaged as described above, additionally monitoring calcofluor-white 161 fluorescence using a standard DAPI filter set to detect the bud scars. To improve bud scar and 162 GS body imaging, 15 µm deep Z-stacks of 3 µm thick slices were captured for each imaged 163 field. Maximum intensity projections were calculated for each Z-stack and, together with the 164 raw data, used to measure cell size (as estimated by cross sectional area at the focal plane), 165 number of bud scars, and count of GS bodies per cell. 166 167
Quantifying rapamycin effects by imaging flow cytometry 168
Gln1-GFP yeast cultures were inoculated from frozen cultures and grown to 0.2 OD/ml in 169 SC in triplicate, then subcultured and grown to approximately 1 OD/ml in SC before the addition 170 of rapamycin (Sigma) in DMSO to reach final concentrations of 200, 100, 20, 1, and 0 nM 171 rapamycin (DMSO only; no differences were observed relative to a control sample without 172 DMSO). Cells were grown an additional 30 h until cultures had passed the diauxic shift before 173 fixing with formaldehyde, as described above, and analyzed using the imaging flow cytometry 174 assay.
RESULTS AND DISCUSSION
177
Formation of GS bodies depends strongly upon available glucose 178
In order to quantify the formation of GS bodies at the single cell level and across many 179 individual cells, we first developed a high-throughput assay based upon imaging flow cytometry: 180
For a given aliquot of Gln1-GFP expressing yeast cells, the cells are fixed with 4% formaldehyde 181 to prevent potential changes in protein localization prior to analysis, then approximately 50,000 182 cells are individually photographed using imaging flow cytometry and the formation of GS 183 bodies measured on a per cell basis using an automated image analysis pipeline ( Figure 1B) . The 184 assay is thus significantly higher in throughput than manual analysis of standard fluorescence 185 microscopy images, and the correspondingly higher cell counts allow for greater precision and 186 statistical power in quantifying the occurrence of GS body formation across populations of cells. 187
Using this assay, we quantified the extent of GS body formation as a function of available 188 glucose in the growth medium, measuring the frequency of cells exhibiting detectable GS bodies 189 as a function of time and for differing concentrations of glucose in the medium ( Figure 1C ).
190
Gln1-GFP tagged yeast cells growing exponentially in 2% glucose were transferred to medium 191 either lacking glucose altogether, or supplemented with varying glucose concentrations, and cell 192 aliquots were assayed using imaging flow cytometry. We found that decreased glucose 193 concentrations led to a corresponding decrease in the onset time of GS body formation ( Figure  194 1C,D), confirming glucose, or possibly cell energy level, dependence to GS body formation.
196
The count of GS bodies per cell also depends upon available glucose levels 197
In the above assays, the frequency of cells forming GS bodies clearly depended upon 198 glucose levels. We further examined the count of GS bodies per cell to determine if the count 199 varied on a cell-to-cell basis. Notably, the majority of cells transferred into glucose dropout 200 medium formed one or two large GS bodies (Figure 2) , as, for example, can be seen in the cell 201 images of Figure 1A . Figure 3B) . Only a small 228 proportion of cells exhibited GS bodies upon treatment with 20 nM or higher rapamycin doses 229 (e.g., Figure 3A) . Notably, many specific cellular mechanisms might contribute to this 230 reduction, including both the decreased cellular protein levels increased autophagy known to 231 follow rapamycin treatment. 
247
We observed a clear correlation between the frequency of GS body formation and 248 measured cell diameter, as assayed using fluorescence microscopy (Pearson r 2 = 0.78; Figure  249 4A). To obtain an independent assay of cell size, we isolated the largest and smallest 5 percent 250 of yeast cells using low-angle forward scattering fluorescence activated cell sorting (FACS), then 251 imaged the cells by fluorescence microscopy, manually measuring cell diameter and scoring the 252 occurrence of GS bodies. This assay confirmed the same general trend (p ≤10 -4 ; Figure 4B ).
253
Due to exponential growth, any mixed population of yeast cells is dominated by young 254 cells, with old cells found only rarely. Thus, in order to directly estimate replicative age by 255 measuring the accumulation of bud scars, we first enriched for yeast cells that had undergone 256 more replicative budding cycles via the use of FACS on the basis of the fluorescent bud scar 257 marker dye calcofluor-white. We then imaged the sorted cells using fluorescence microscopy 258 and directly counted both bud scars and GS bodies per cell (e.g., as in Figure 5A ).
259
The frequency of cells with GS bodies increased steadily with cell age, as measured by 260 bud scar count, from a base rate of ~76% in unbudded cells and saturating at approx. 95% of the 261 population among cells with 10 or more bud scars ( Figure 5B) . Moreover, cells with more bud 262 scars were found to be more likely to contain a higher count of GS bodies per cell (though the 263 correlation was not linear) with the largest increase in the mean number of GS bodies per cell 264 occurring between cells with no bud scars and cells with one bud scar ( Figure 5C ). The 265 difference was more marked when we narrowed the analysis strictly to pairs of mother and 266 daughter cells that had yet to undergo cell separation. Mother cells were significantly more likely 267 to contain GS bodies than their connected daughter cells, and also to exhibit higher counts of GS 268 bodies per cell (p ≤ 10 -10 ; Figure 5D) Removal of glucose from the growth medium slows and eventually halts glycolysis as residual 520 glucose is depleted, and leads to strong induction of one or two visible foci per cell after 2h. 521 Direct inhibition of glycolysis by the addition of a competitive inhibitor of glucose hexokinase, 522 2-deoxyglucose (2DG; added at 2%), induces formation of many small foci rather than one or 523 two large foci, suggesting that the assembly of one or two large foci per cell may be an energy 524 dependent process. 525 
